Notification No. 12/2021
Date: September 30, 2021
Subject: Temporary concessional/exempt GST rates on COVID-19 related medicines.
Description:
This notification grants Nil or 2.5% CGST on specified COVID-19 medicines such as Tocilizumab, Amphotericin-B, Remdesivir, Favipiravir, 2-Deoxy-D-Glucose, etc. The concession is time-bound and aimed at reducing treatment cost during the pandemic.
Issued for earlier notification?
No — this is a standalone temporary relief notification.